PCVX
Companies
NASDAQ
Vaxcyte Inc.
Health Care
$33.25
-$48.61 (-59.38%)
Price Chart
Overview
About PCVX
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
Market Cap
$7.7B
Volume
81.4M
Avg. Volume
83.4M
P/E Ratio
-7.764331
Dividend Yield
0.00%
Employees
210.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.55
Low Correlation
Volatility
High (0.53)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PCVX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$7.7B
Volume81.4M
P/E Ratio-7.76
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025